Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › AXSM

SUPERSTRING CAPITAL MANAGEMENT LP position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 53,916 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$13.2M, representing 8.33% of its reported portfolio and ranking #2 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed AXSM holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)53.92K sh
Reported value held$13.20M
Portfolio Weight8.33%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's AXSM position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in AXSM in Q4 2023 at 16,179 shares (US$1.3M). The position peaked in Q2 2026 at 53,916 shares, worth US$13.2M. Across 6 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 53,916 shares valued at US$13.2M — an increase of 42,699 shares quarter over quarter.. Notable position changes include a 126% increase in Q1 2024 (shares were roughly flat over the following quarter), a 70% trim in Q1 2026 (shares rose 45% over the following quarter), a 381% increase in Q2 2026 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 16.18K $1.29M New
Q1 2024 36.61K $2.92M Add
Q4 2024 4.27K $361.12K New
Q4 2025 37.43K $6.84M New
Q1 2026 11.22K $1.90M Reduce
Q2 2026 53.92K $13.20M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held AXSM?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed AXSM holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in AXSM?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 53.92K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $13.20M, representing 8.33% of its reported portfolio and ranking #2.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling AXSM?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in AXSM. The position peaked in Q2 2026 at 53.92K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.